ArcticZymes today announced the expansion of their polymerase portfolio. The IsoPol™ SD⁺ and IsoPol™ BST⁺ deliver low temperature isothermal polymerases, one with increased strand displacement, and the second an improvement over existing Bacillus stearothermophilus available today.
IsoPol™ SD+ is a DNA polymerase with stronger strand displacement activity, and higher salt tolerance compared to ArcticZymes first IsoPolTM polymerase. IsoPol™ SD+ is available for shipment during January 2018.
IsoPol™ Bst+ is a polymerase with stronger strand displacement and higher salt tolerance compared to the thermostable Bst wild type. IsoPol™ SD+ will be available for shipment during first quarter 2018.
ArcticZymes strategy has been to innovate the next generation of polymerases to serve the unmet demands necessary to facilitate the development of novel molecular technologies. In combination with a variety of attractive features engineered into the enzymes ArcticZymes is able to offer a diverse range of unique IsoPol™ polymerases to its commercial partners and end users.
For more details about the IsoPol™ polymerase portfolio visit our technology page.
Disclaimer: These products are intended for further manufacturing use or research use only. Certain applications of ArcticZymes AS products may require licenses from others. It is the expressed duty of any receiver of ArcticZymes AS products to acquire such licenses, if necessary. To the extent allowed by law, ArcticZymes AS will not be liable for damages, whether direct, indirect, incidental, or consequential in connection with or arising from this document, including the use of it. ArcticZymes AS products may be covered by pending or issued patents, designs or design applications and/or trademarks or trademark applications or any other registered or unregistered Intellectual Property Right.